Roth Capital reiterated coverage on Dare Bioscience with a new price target

6/30/21 9:55:24 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Roth Capital reiterated coverage of Dare Bioscience with a rating of Buy and set a new price target of $11.00 from $9.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DARE

Date	Price Target	Rating	Analyst
6/30/2021	$9.00 → $11.00	Buy	Roth Capital